Editas Medicine Announces Q3 Results: Both Loss and Revenue Beat Expectations
EDIT Editas Medicine Inc
$2.75 +7.00%
View chart & analysis → - 1Editas Medicine Inc. reported a loss of $23.4 million for the third quarter.
- 2Editas Medicine Inc.'s loss per share of 15 cents was lower than the analyst estimate of 21 cents.
- 3Editas Medicine Inc.'s revenue of $10.4 million for the period exceeded the $1.7 million revenue estimate from 3 analysts surveyed by Zacks.
So what's the key point?
Editas Medicine Inc. reported a smaller loss and higher revenue than expected. The results came in better than what experts had predicted.
Source Associated Press · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.